Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5638-5643
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5638
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5638
Figure 3 Effect of GM6001, an MMP inhibitor, on LPA-stimulated c-Met transactivation in colon cancer cells.
Human colon cancer LoVo cells were serum-starved for 24 h and pre-incubated with the indicated concentrations of GM6001 for 30 min. After incubation with 10 µmol/L LPA for 2 min, cell lysates were obtained and IP with anti-c-Met. Immunoprecipitates were immunoblotted with anti-phosphotyrosine. Then the membrane was stripped and immunoblotted with anti-c -Met as a control. The same experiments were performed using anti-EGFR as a control for the inhibitory effect of GM6001.
- Citation: Shida D, Kitayama J, Yamaguchi H, Yamashita H, Mori K, Watanabe T, Nagawa H. Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells. World J Gastroenterol 2005; 11(36): 5638-5643
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5638.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5638